Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8778312 | European Urology | 2018 | 12 Pages |
Abstract
We reviewed all previous studies assessing the impact of 68Gallium prostate-specific membrane antigen positron emission tomography (68Ga-PSMA PET) in patients with prostate cancer. We found that 68Ga-PSMA PET altered the management in approximately half of the patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sangwon Han, Sungmin Woo, Yeon Joo Kim, Chong Hyun Suh,